维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

7篇 您的检索式：作者名="Podsadecki"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	ABT-450, Ritonavir, Ombitasvir, and Dasabuvir Achieves 97% and 100% Sustained Virologic Response With or Without Ribavirin in Treatment-experienced Patients with HCV Genotype 1b Infection显示文摘	Pietro Andreone Massimo G. Colombo Jeffrey V. Enejosa Iftihar Koksal Peter Ferenci Andreas Maieron Beat Müllhaupt Yves Horsmans Ola Weiland Henk W. Reesink Lino Rodrigues Yiran B. Hu Thomas Podsadecki Barry Bernstein	2014	Gastroenterology2014，，：	2
	2	A lopinavir/ ritonavir-based once-daily regimen results in better compliance and is non-inferior to a twice-daily regimen through 96 weeks 显示文摘	Molina JM Podsadecki TJ Johnson MA	2007	AIDS Res Hum Retroviruses2007，23，12：	1
	3	Similar safety and efficacy of once- and twice-daily lopinavir/ritonavir tablets in treatment-experienced HIV-1-infected subjects at 48 weeks 显示文摘	Zajdenverg R Podsadecki TJ Badal-Faesen S	2010	J Acquir Immune Defic Syndr2010，54，2：	1
	4	O057 : Long-term follow-up of treatment-emergent resistance-associated variants in NS3, NS5A and NS5B with paritaprevir/r-, ombitasvir- and dasabuvir-based regimens显示文摘	P. Krishnan R. Tripathi G. Schnell T. Reisch J. Beyer T. Dekhtyar M. Irvin W. Xie L. Larsen T. Podsadecki T. Pilot-Matias C. Collins	2015	Journal of Hepatology2015，，：	1
	5	3 SAFETY AND EFFICACY OF INTERFERON-FREE REGIMENS OF ABT-450/r, ABT-267, ABT-333 +/? RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GT1 INFECTION: RESULTS FROM THE AVIATOR STUDY显示文摘	K.V. Kowdley E. Lawitz F. Poordad D.E. Cohen D. Nelson S. Zeuzem G.T. Everson P. Kwo G.R. Foster M. Sulkowski W. Xie L. Larsen A. Khatri T. Podsadecki B. Bernstein	2013	Journal of Hepatology2013，，：	1
	6	A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1显示文摘	Eric Lawitz Fred Poordad Kris V. Kowdley Daniel E. Cohen Thomas Podsadecki Sara Siggelkow Lois Larsen Rajeev Menon Gennadiy Koev Rakesh Tripathi Tami Pilot-Matias Barry Bernstein	2013	Journal of Hepatology2013，，1：	1
	7	A phase 2a trial of 12-week interferon-free therapy with two direct-acting antivirals (ABT-450/r, ABT-072) and ribavirin in IL28B C/C patients with chronic hepatitis C genotype 1显示文摘	Eric Lawitz Fred Poordad Kris V. Kowdley Daniel E. Cohen Thomas Podsadecki Sara Siggelkow Lois Larsen Rajeev Menon Gennadiy Koev Rakesh Tripathi Tami Pilot-Matias Barry Bernstein	2013	Journal of Hepatology2013，，1：	1

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费